Cognilum TM: Light Treatment Condition

DEVICE3 trials

Sponsors

JelikaLite LLC, State University of New York - Upstate Medical University

Conditions

Autism Spectrum Disorder

Unknown Phase

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children

CompletedNCT04660552

JelikaLite LLCAutism Spectrum Disorder

Start: 2020-11-15End: 2023-12-30Updated: 2026-07-07

Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder

RecruitingNCT06006637

State University of New York - Upstate Medical UniversityAutism Spectrum Disorder

Start: 2023-10-17End: 2026-08-15Target: 80Updated: 2025-10-14

Transcranial Photobiomodulation for Reducing Autism Symptoms in Children - Open Label Study (TPBMASDOL)

CompletedNCT06359080

JelikaLite LLCAutism Spectrum Disorder

Start: 2022-05-08End: 2022-12-11Updated: 2026-07-07

Related Papers

Transcranial photobiomodulation for reducing symptoms of autism spectrum disorder and modulating brain electrophysiology in children aged 2–7: an open label study

Frontiers in Child and Adolescent Psychiatry2025-01-29

Transcranial photobiomodulation in children aged 2–6 years: a randomized sham-controlled clinical trial assessing safety, efficacy, and impact on autism spectrum disorder symptoms and brain electrophysiology

Frontiers in Neurology2024-04-2614 citations